Agilent Technologies releases liquid chromatography system at Analytica 2016

Agilent Technologies Inc. (NYSE: A) today introduced InfinityLab, a product family of liquid chromatography instruments, columns and supplies. A key element of this introduction is the new Agilent 1260 Infinity II liquid chromatography system, which will bring high-end technology from Agilent’s flagship 1290 Infinity II LC into the company’s core platform.

The Agilent 1220 Infinity II LC (available in August), 1260 Infinity II LC (announced today), together with the current 1290 Infinity II LC systems create the new InfinityLab LC Series.

The InfinityLab columns and supplies announced today allow tracking of critical method information for high data confidence and offer ergonomic designs for exceptional system usability.

Agilent introduced the new product family at Analytica, an international trade fair for laboratory technology, now under way in Munich.

“The 1260 Infinity II LC system as the new core platform of the InfinityLab LC Series represents a considerable technology refresh to increase customer’s efficiency in three ways: delivering trusted analytical data, outstanding usability, and easy integration into existing lab environments,” said Stefan Schuette, vice president and general manager of Agilent’s Liquid Phase Separations Division.

“The InfinityLab columns and supplies are designed to fit perfectly with our new InfinityLab LC Series,” said Helen Stimson, vice president and general manager of Agilent’s Chemistries and Supplies Division.  “These products are designed to improve overall usability and reduce laboratory operating costs.”

At Analytica, Agilent is also showcasing the new OpenLAB Chromatography Data System version 2.0, designed to foster more efficient, cost-effective laboratory operations through its outstanding ease of use and speed.

Agilent’s InfinityLab instruments, columns and supplies, OpenLAB software, and CrossLab services provide the end-to-end solution laboratories need to ensure the best analytical and business outcomes for customers.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Agilent Technologies - Mass Spectrometry. (2019, June 19). Agilent Technologies releases liquid chromatography system at Analytica 2016. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20160513/Agilent-Technologies-releases-liquid-chromatography-system-at-Analytica-2016.aspx.

  • MLA

    Agilent Technologies - Mass Spectrometry. "Agilent Technologies releases liquid chromatography system at Analytica 2016". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20160513/Agilent-Technologies-releases-liquid-chromatography-system-at-Analytica-2016.aspx>.

  • Chicago

    Agilent Technologies - Mass Spectrometry. "Agilent Technologies releases liquid chromatography system at Analytica 2016". News-Medical. https://www.news-medical.net/news/20160513/Agilent-Technologies-releases-liquid-chromatography-system-at-Analytica-2016.aspx. (accessed April 25, 2024).

  • Harvard

    Agilent Technologies - Mass Spectrometry. 2019. Agilent Technologies releases liquid chromatography system at Analytica 2016. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20160513/Agilent-Technologies-releases-liquid-chromatography-system-at-Analytica-2016.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.